Thermo Fisher Scientific | TMO - Créances Commerciales





Créances Commerciales Changement Date
Abbott USD 10.57B 171M 2025-12
Agilent USD 1.5B 23M 2026-03
Becton, Dickinson and Co. USD 2.2B 303M 2026-03
Bio Techne USD 214.56M 29.95M 2026-03
Bio-Rad Laboratories USD 460.6M 4.1M 2025-12
Boston Scientific USD 2.93B 98M 2025-12
Bruker USD 542.7M 2.2M 2026-03
Charles River Laboratories USD 700.25M 727.92M 2026-03
Danaher USD 4.76B 845M 2026-03
Dentsply International USD 622M 66M 2026-03
Edwards Lifesciences USD 912.1M 19.3M 2025-12
General Electric Aerospace USD 22.18B 6.89B 2026-03
Henry Schein USD 1.72B 68M 2026-03
Illumina USD 738M 116M 2026-03
Intuitive Surgical USD 1.6B 68.3M 2026-03
IQVIA Holdings USD 3.38B 52M 2026-03
Laboratory Of America USD 2.45B 189.8M 2026-03
Medtronic USD 6.36B 30M 2025-12
Mettler Toledo International USD 708.21M 70.04M 2026-03
Myriad Genetics USD 115.3M 2.7M 2025-12
Olympus JPY 334.31B 55.98B 2026-03
OraSure Technologies USD 22.2M 2.1M 2025-12
Quest Diagnostics USD 1.59B 179M 2026-03
Repligen USD 151.55M 7.03M 2026-03
Revvity USD 691.38M 53.29M 2026-03
Stryker USD 3.57B 468M 2026-03
Thermo Fisher Scientific USD 9.2B 304M 2026-03
Veracyte USD 50.11M 5.45M 2026-03
Waters USD 1.76B 930.16M 2026-03
Zimmer Biomet Holdings USD 1.73B 24.2M 2026-03